Trwa ładowanie...

Notowania

SOPHARMA: strona spółki

6.02.2023, 13:44

SPH sales revenues for January 2023

“Sopharma” AD (the Company) notifies that for January 2023 the Company recorded an increase in sales of 33% compared to the same month of the previous year, incl. 27% decrease in domestic sales and 174% increase in export sales.

Załączniki

Pobierz załącznik 1

Inne komunikaty

Data	Tytuł	Kurs	Zmiana
2024-09-19	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	12,65	0,00
2024-09-18	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,00	-2,69
2024-09-17	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,00	0,00
2024-09-16	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,00	0,00
2024-09-13	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	13,20	-4,17
2024-09-12	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,40	-8,33
2024-09-11	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,40	0,00
2024-09-10	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,40	0,00
2024-09-10	SPH Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,40	0,00
2024-09-09	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	14,40	0,00

Wszystke komunikaty